Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China

Trial Identifier: MEQ00076
Sponsor: Sanofi
Start Date: September 2025
Primary Completion Date: May 2026
Study Completion Date: September 2026
Condition: Healthy Volunteers; Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CHINA Jingxi, CHINA, 533899
CHINA Liuzhou, CHINA, 545100
CHINA Tengzhou, CHINA, 543399
CHINA, Guangxi Nanning, Guangxi, CHINA, 530028